Industry-Sponsored Symposium - Treatment Selection in Ulcerative Colitis: Optimizing Outcomes through Patient-Centered Decision Making

Marla C. Dubinsky, MD, and Bruce E. Sands, MD, MS, FACG

This activity is supported by an educational grant from Lilly.

This interactive educational program is designed to provide gastrointestinal healthcare providers with patient-centered strategies to individualize therapy selection in ulcerative colitis. Using a combination of didactic lecture and animated/video simulation case challenges, this program aims to increase clinician knowledge of the safety, efficacy, and mechanism of action of recently approved and emerging therapies; and improve their ability to incorporate the assessment of bowel urgency into management strategies for patients with ulcerative colitis.

Open to all ACG 2023 attendees, industry-sponsored symposia provide additional educational opportunities. These programs are independent of the ACG 2023 Annual Scientific Meeting and Postgraduate Course programs. ACG is not the continuing medical education provider of these programs. For more information, see the company sponsor.

Use the Register button or register at http://www.mlg-uc.com.